FDA approves wider use of aerosolized pentamidine to prevent pneumocystis pneumonia.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000336:Aerosols; D015507:Drugs, Investigational; D006801:Humans; D010419:Pentamidine / Q000008:administration & dosage / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration
D000336:Aerosols; D015507:Drugs, Investigational; D010419:Pentamidine